Recent Advances in Intelligent Wearable Medical Devices Integrating Biosensing and Drug Delivery
Abstract
The primary roles of precision medicine are to perform real‐time examination, administer on‐demand medication, and apply instruments continuously. However, most current therapeutic systems implement these processes separately, leading to treatment interruption and limited recovery in patients. Personalized healthcare and smart medical treatment have greatly promoted research on and development of biosensing and drug‐delivery integrated systems, with intelligent wearable medical devices (IWMDs) as typical systems, which have received increasing attention because of their non‐invasive and customizable nature. Here, the latest progress in research on IWMDs is reviewed, including their mechanisms of integrating biosensing and on‐demand drug delivery. The current challenges and future development directions of IWMDs are also discussed.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Intelligent wearable medical devices (IWMDs) facilitate real-time monitoring, diagnosis, and treatment of various medical conditions.
“With the introduction of flexible electronics, the development of intelligent wearable medical devices (IWMDs) has become a reality, facilitating real-time monitoring, diagnosis, and treatment of various medical conditions (Tan et al. 2022).”
From Artificial intelligence enhanced sensors - enabling technologies to next-generation healthcare and biomedical platform (2023) · cites this paper as Tan et al. 2022
IWMDs provide predictive bio-analysis, timely treatment intervention, and improved drug efficacy, thereby promoting precision medicine.
“Through tracking physiological and pathological factors and delivering therapeutic agents acting in an on-demand manner, IWMDs have become indispensable in providing predictive bio-analysis, timely treatment intervention, and improved drug efficacy, thereby promoting precision medicine (cheol Jeong et al. 2018; Tan et al. 2022).”
From Artificial intelligence enhanced sensors - enabling technologies to next-generation healthcare and biomedical platform (2023) · cites this paper as Tan et al. 2022
The citation lists haven’t been fetched yet
References 260 · Cited by 187
- Authors
- Tan, M., Xu, Y., Gao, Z., Yuan, T., Liu, Q., Yang, R., Zhang, B., & Peng, L.
- Affiliations
- Zhejiang University (CN)
- Xidian University (CN)
- Macau University of Science and Technology (MO)
- Corresponding author
- Peng, Lihua
- Venue
- Advanced Materials
- Publisher
- Wiley
- Published
- 2022-04-28
- Volume
- 34
- Issue
- 27
- Pages
- e2108491-e2108491
- ISSN
- 0935-9648 (ISSN-L)
- 1521-4095
- OpenAlex
- W4205969521
- Semantic Scholar
- c9ba119e31b878a39b3565aaf08f51acf92c7cff
- Cited by
- 187
- References
- 260
- Citations by year
- 2026: 36 · 2025: 50 · 2024: 46 · 2023: 43 · 2022: 12
- FWCI
- 3.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Advanced Materials (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Key Research and Development Program of China (2018YFC1105404)
- National Natural Science Foundation of China (81473145)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Advanced Sensor and Energy Harvesting Materials
- Physical Sciences › Engineering › Biomedical Engineering › Non-Invasive Vital Sign Monitoring
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Keywords
- biosensing, on-demand drug delivery, precision medicine, personalized healthcare, non-invasive monitoring, continuous monitoring
- MeSH terms
- Wearable Electronic Devices, Pharmaceutical Preparations, Humans, Biosensing Techniques, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
